Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples